News & Updates

Short nighttime sleepers are at higher risks of long COVID, depression and cardiovascular (CV) diseases than normal sleepers, according to three recent studies by researchers from the Chinese University of Hong Kong (CUHK).

Long-term treatment with methylphenidate does not increase risks of growth impairment and psychiatric or neurological adverse events (AEs) in children and adolescents with attention deficit hyperactivity disorder (ADHD), according to the international ADDUCE study co-led by the University of Hong Kong (HKU) and the University of Melbourne.

Women with HIV who use antiretroviral therapy (ART) combinations such as tenofovir alafenamide (TAF) with a cobicistat-boosted integrase inhibitor (INSTI) or protease inhibitor (PI) appear to frequently show somatic depressive symptoms, according to data from the Women’s Interagency HIV Study (WIHS) presented at CROI 2023.

Mindfulness and cognitive behavioural therapy (CBT) appear beneficial for prostate cancer survivors and their partners who are dealing with sexual dysfunction, a study has shown.

Polygenic risk scores (PRS) for bipolar disorder, major depression, and schizophrenia are predictive of episode polarity and psychotic symptoms in a similar manner among individuals with bipolar disorder, suggests a recent study.

When added to standard treatment, mindfulness-based cognitive therapy (MBCT) may have favourable effects for patients with bipolar disorder and moderate to severe levels of depression and functional impairment, according to a study.

One in six people with poorly controlled type 2 diabetes (T2D) in Singapore experiences diabetes distress, with the risk factors including younger age, previous tobacco use, kidney disease history, and depressive symptoms, as reported in a study.

The beneficial effect of moderate alcohol consumption in preventing depression appears causal, suggest the results of a recent study.